Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
<strong>Purpose</strong> Minimal residual disease (MRD) and genetic abnormalities are important risk factors for outcome in acute lymphoblastic leukemia. Current risk algorithms dichotomize MRD data and do not assimilate genetics when assigning MRD risk, which reduces predictive accuracy...
Κύριοι συγγραφείς: | O'Connor, D, Enshaei, A, Bartram, J, Hancock, J, Harrison, C, Hough, R, Samarasinghe, S, Schwab, C, Vora, A, Wade, R, Moppett, J, Moorman, A, Goulden, N |
---|---|
Μορφή: | Journal article |
Έκδοση: |
American Society of Clinical Oncology
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
ανά: Moorman, A, κ.ά.
Έκδοση: (2007) -
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
ανά: O'Connor, D, κ.ά.
Έκδοση: (2017) -
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.
ανά: Moorman, A, κ.ά.
Έκδοση: (2014) -
Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.
ανά: Cutting, R, κ.ά.
Έκδοση: (2008) -
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
ανά: Patrick, K, κ.ά.
Έκδοση: (2014)